University of Michigan Medical School

What University of Michigan Medical School does

University of Michigan Medical School is a public, state-supported academic medical institution founded in 1848 (or 1850 per one source) and part of the University of Michigan system, operating under the Michigan Medicine brand in Ann Arbor. The institution delivers medical education across a full developmental pipeline: a four-year MD program with an Impact Curriculum and Paths of Excellence; a combined MD|PhD Medical Scientist Training Program; 14 PhD disciplines through the Program in Biomedical Sciences (PIBS) with 500+ mentors; master's programs; ACGME-accredited residency and fellowship programs; postdoctoral training; and non-degree pathways (K-12 Pathways, Postbac MEDPREP, U-M PRIME).

Its core technology platform spans medical education infrastructure, clinical research capacity, and proprietary AI assets, most notably the Prima AI model for brain MRI interpretation (97.5% accuracy across 50+ neurological conditions, trained on 220,000+ MRI studies and validated over a one-year health-system study of 29,431 scans). Additional AI/NLP work is evidenced by the analysis of 218 million EHR notes for the emoji-use study. The medical school also invests in novel medical devices such as BiliRoo, a low-cost infant jaundice treatment device.

The business model is anchored in three revenue streams: tuition and fees for MD, master's, and other educational programs; federal and institutional research grants (e.g., a $16.5M NIH award for chronic lower back pain research, plus a $1.1M AMA grant); and clinical care services delivered through Michigan Medicine and partner sites including the VA Ann Arbor Healthcare System. The go-to-market model is hybrid: admissions-driven student recruitment across global and regional geographies, research collaboration and grant capture, and clinical service delivery across the Midwest.

Name

University of Michigan Medical School

Legal name

Regents of the University of Michigan

Website

https://medicine.umich.edu

Company type

Private

Founded year

1850

Operating status

Operating

Headcount range

10,001+ employees

Short description

University of Michigan Medical School is a public medical school in Ann Arbor, Michigan that delivers MD, MD|PhD, PhD, master's, residency, and postdoctoral training; conducts biomedical research (including the Prima AI brain MRI diagnostic model); and provides clinical care through Michigan Medicine.

Ownership category

akta.pro rank

Product category

Medical Education

NAICS

Colleges, Universities, and Professional Schools (6113), General Medical and Surgical Hospitals (62211)

SIC

Services-Hospitals (8060), Services-General Medical & Surgical Hospitals, Nec (8062), Services-Offices & Clinics Of Doctors Of Medicine (8011)

akta.pro primary industry

Medical Schools (MD/DO Granting) (EDAHAGAB)

akta.pro secondary industries

Biomedical Sciences & Medical Research Institutes (University-Based) (EDAHAGAI), Public Research Universities with Academic Medical Centers (AMCs) (EDAHAAAC)

Keywords

• Medical education programs
• Biomedical research training
• Graduate medical education
• Residency fellowship training
• Clinical research services

Headquarters

HQ city

Ann Arbor

HQ country

United States

HQ region

North America

Offices2 records

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Technology or R&D, Operations, Infrastructure, Marketing or Sales

Revenue model

1. Tuition and Fees: Revenue from MD program tuition, master's programs tuition, and various educational fees for medical and graduate education programs.
2. Research Grants and Funding: NIH and other federal research grants funding medical research, including a $16.5M NIH grant for chronic lower back pain treatment research.
3. Patient Care Services: Clinical revenue through Michigan Medicine patient care services provided by faculty, residents, and fellows.

Pricing tiers

Go-to-market motion1 record

Distribution channels4 records

Marketing channels4 records

Core offering

The University of Michigan Medical School operates a comprehensive medical and biomedical education platform offering MD, MD|PhD, PhD (14 disciplines), Master's, Residency & Fellowship, Postdoctoral, and Non-Degree programs. It also delivers clinical care through Michigan Medicine and conducts biomedical research, including development of AI diagnostic tools and medical devices.

Product overview

The University of Michigan Medical School offers a comprehensive portfolio of educational programs including the MD Program (four-year medical degree), MD|PhD combined program (MSTP for medical scientist training), 14 PhD disciplines through PIBS, Master's programs, Residency & Fellowship programs, Postdoctoral training, and Non-Degree programs. Additionally, the institution has developed AI-powered research tools including Prima, an AI model for brain MRI diagnosis, and BiliRoo, a medical device for infant jaundice treatment. The core offering is a platform of educational programs that prepare students for careers in medicine and biomedical research.

Differentiator

Problem solved

Functional benefit

Products and services

• MD Program

Quantifiable outcome

• 97.5% accuracy in brain MRI diagnosis
• +4 more outcomes

Named customers1 record

Segments4 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability4 records

Feature2 records

Partnerships

Three partnerships are on record, tiered core and flagship.

• University of New South WalescoreStrategic or Co-development PartnerCollaborative research with University of New South Wales published in JAMA Network Open on US dental opioid prescribing patterns compared to peer nations.
• Veterans Affairs Ann Arbor Healthcare SystemcoreStrategic or Co-development PartnerJoint development of clinical guidance for managing suspected urinary tract infections in telehealth and virtual visits patients, addressing gaps in virtual care settings.
• Dr. Charles Sawyers (Memorial Sloan Kettering Cancer Center)flagshipStrategic or Co-development PartnerJoint recipients of 2026 Harrington Prize for Innovation in Medicine for breakthroughs in prostate cancer genetics and therapies, including TMPRSS2-ERG identification and development of androgen receptor inhibitors and PARP inhibitors.

Scale indicators6 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• Stanford University School of Medicine: Stanford School of Medicine offers MD, MD/PhD, PhD, and master's programs alongside a leading academic medical center, with strong AI/machine learning and biomedical informatics research. Comparable to U-M in research output, MD curriculum design, and biotech-adjacent innovation.
• Washington University School of Medicine in St. Louis: WashU Medicine offers MD, MD/PhD, PhD, and residency/fellowship programs and is one of the top NIH-funded medical schools. Highly comparable to U-M in research intensity, MD curriculum, and biomedical training.
• Yale School of Medicine: Yale School of Medicine offers MD, MD/PhD, PhD, and residency programs alongside Yale New Haven Health. Directly comparable to U-M in research output, MD education, and biomedical training programs.
• Johns Hopkins University School of Medicine: Johns Hopkins School of Medicine is one of the most prominent MD-granting medical schools in the U.S., offering MD, MD/PhD, PhD, residency, and fellowship programs alongside an integrated academic medical center. It is a direct peer in medical education, biomedical research scale, and NIH funding competitiveness.
• Perelman School of Medicine at the University of Pennsylvania: Penn Medicine offers MD, MD/PhD, PhD, and residency programs and is consistently a top NIH-funded institution. Comparable to U-M in research scale, clinical training, and academic medical center operations.
• Harvard Medical School: Harvard Medical School offers MD, MD/PhD (HST and DMD pathways), PhD, and master's programs and is a top-tier research medical school with extensive NIH funding. It is directly comparable to U-M in curriculum structure, biomedical research breadth, and academic medical center integration.
• University of California, San Francisco School of Medicine: UCSF School of Medicine is a top public medical school offering MD, MD/PhD, PhD, and residency programs with significant NIH funding. Direct peer to U-M as another leading public medical school with strong biomedical research and an integrated academic health system.
• Duke University School of Medicine: Duke School of Medicine offers MD, MD/PhD, PhD, and residency programs with notable AI/biomedical informatics research. Comparable to U-M in curriculum innovation, research output, and academic medical center integration.
• Columbia University Vagelos College of Physicians and Surgeons: Columbia VP&S offers MD, MD/PhD, PhD, and residency programs with a major academic medical center (NewYork-Presbyterian). Comparable to U-M in MD education, biomedical research, and clinical training programs.

Broad incumbents

• Mayo Clinic Alix School of Medicine: Mayo Clinic Alix School of Medicine offers MD and MD/PhD programs embedded within the broader Mayo Clinic health system. Comparable as a peer medical school, though Mayo's integrated single-hospital system model differs from U-M's broader multi-department public-university structure.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat6 records

Key risks5 records

Key highlights6 records

Customer concentration

• Xx.com/umichmedicine

Revenue estimate

Valuation estimate

Number of profiles

Profiles8 records

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about University of Michigan Medical School